Cargando…

Evaluation of two commercial and two non-commercial immunoassays for the detection of prior infection to SARS-CoV-2

BACKGROUND: Seroepidemiology is an important tool to characterize the epidemiology and immunobiology of SARS-CoV-2 but many immunoassays have not been externally validated raising questions about reliability of study findings. To ensure meaningful data, particularly in a low seroprevalence populatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nilles, Eric J., Karlson, Elizabeth W., Norman, Maia, Gilboa, Tal, Fischinger, Stephanie, Atyeo, Caroline, Zhou, Guohai, Bennett, Christopher L., Tolan, Nicole V., Oganezova, Karina, Walt, David R., Alter, Galit, Simmons, Daimon P., Schur, Peter, Jarolim, Petr, Baden, Lindsey R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325183/ https://www.ncbi.nlm.nih.gov/pubmed/32607518 http://dx.doi.org/10.1101/2020.06.24.20139006

Ejemplares similares

Evaluation of 5 Commercially Available Zika Virus Immunoassays
por: Safronetz, David, et al.
Publicado: (2017)

Comparison of Two Commercially Available Immunoassays for the Measurement of Bovine Cardiac Troponin I in Cattle With Induced Myocardial Injury
por: Smith, Joe S., et al.
Publicado: (2020)

Analysis of COVID-19 convalescent plasma for SARS-CoV-2 IgG using two commercial immunoassays
por: DomBourian, Melkon G., et al.
Publicado: (2020)

Validation of dried blood spot sample modifications to two commercially available COVID-19 IgG antibody immunoassays
por: Zava, Theodore T, et al.
Publicado: (2020)

Evaluation of three commercially-available chikungunya virus immunoglobulin G immunoassays
por: De Salazar, Pablo M, et al.
Publicado: (2017)

Validation of a commercial enzyme immunoassay to assess urinary oxytocin in humans
por: Schaebs, Franka S, et al.
Publicado: (2021)

Clinical evaluation of commercial automated SARS-CoV-2 immunoassays
por: Kittel, Maximilian, et al.
Publicado: (2021)

Validation of a commercially available SARS-CoV-2 serological immunoassay
por: Meyer, B., et al.
Publicado: (2020)

Quantification of SARS-CoV-2 antibodies with eight commercially available immunoassays
por: Weidner, Lisa, et al.
Publicado: (2020)

Validation of Commercial SARS-CoV-2 Immunoassays in a Nigerian Population
por: Ige, Fehintola, et al.
Publicado: (2021)

The Evaluation of Two Commercially Available, Portable Raman Systems
por: Mosier-Boss, Pamela A., et al.
Publicado: (2013)

Use of a commercial enzyme immunoassay to monitor dengue virus replication in cultured cells
por: Ludert, Juan E, et al.
Publicado: (2008)

Clinical Laboratory Utility of a Humanized Antibody in Commercially Available Enzyme Immunoassays for Coccidioidomycosis
por: Grill, Francisca J., et al.
Publicado: (2022)

Performance and correlation of ten commercial immunoassays for the detection of SARS-CoV-2 antibodies
por: Lokida, Dewi, et al.
Publicado: (2022)

Comparative Evaluation of Four Commercially Available Immunoassays for Therapeutic Drug Monitoring of Infliximab and Adalimumab
por: Rissel, Florian, et al.
Publicado: (2023)

A comparison of 7 commercial anti-SARS-CoV-2 antibody immunoassays
por: Swadźba, Jakub, et al.
Publicado: (2020)

Liver Fibrosis Index FIB‐4 Is Associated With Mortality in COVID‐19
por: Li, Yijia, et al.
Publicado: (2020)

Effects of two commercial diets and two supplements on urinary pH in dogs
por: Igreja, Inês Alcaide, et al.
Publicado: (2023)

The Antibodiome—Mapping the Humoral Immune Response to HIV
por: Butler, Audrey L., et al.
Publicado: (2019)

Perspectives on Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 and Its Implications for Diagnostics, Biology, and Clinical Management
por: Simmons, Daimon P., et al.
Publicado: (2022)

Detection of SARS-CoV-2 Antibodies in Diagnosis and Treatment of COVID-19
por: Simmons, Daimon P., et al.
Publicado: (2022)

Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity
por: Loos, Carolin, et al.
Publicado: (2020)

In Vitro Dissolution Profile of Two Commercially Available Iron Preparations
por: Patrício, José P. H., et al.
Publicado: (2012)

Comparative study of two commercially pure titanium casting methods
por: RODRIGUES, Renata Cristina Silveira, et al.
Publicado: (2010)

Two‐year experience with the commercial Gamma Knife Check software
por: Xu, Andy (Yuanguang), et al.
Publicado: (2016)

A comparison of two commercial treatment‐planning systems for IMRT
por: Petric, M. Peter, et al.
Publicado: (2005)

EPID dosimetry for pretreatment quality assurance with two commercial systems
por: Bailey, Daniel W., et al.
Publicado: (2012)

Comparison of two commercial detector arrays for IMRT quality assurance
por: Li, Jonathan G., et al.
Publicado: (2009)

Virological study of two commercial pig herds with respiratory disease
por: Watt, R.G.
Publicado: (1978)

Comparison of Medication Alerts from Two Commercial Applications in the USA
por: Shah, Sonam N., et al.
Publicado: (2021)

Qualitative and quantitative studies on two commercial specifications of Polygonatum odoratum
por: Nan, Yi, et al.
Publicado: (2023)

The Effect of Vaccine Type and SARS-CoV-2 Lineage on Commercial SARS-CoV-2 Serologic and Pseudotype Neutralization Assays in mRNA Vaccine Recipients
por: Tolan, Nicole V., et al.
Publicado: (2022)

Comparison of commercial lateral flow immunoassays and ELISA for SARS-CoV-2 antibody detection
por: Serrano, Maria Martínez, et al.
Publicado: (2020)

Evaluation of the SARS-CoV-2-IgG response in outpatients by five commercial immunoassays
por: Wellinghausen, Nele, et al.
Publicado: (2020)

First amyloid β1‐42 certified reference material for re‐calibrating commercial immunoassays
por: Boulo, Sébastien, et al.
Publicado: (2020)

Rheumatoid factor and falsely elevated results in commercial immunoassays: data from an early arthritis cohort
por: Gehin, Johanna E., et al.
Publicado: (2021)

Commercialism
por: Buckley, J. P.
Publicado: (1916)

Commercialism
Publicado: (1921)

A single immunization with a modified vaccinia Ankara vectored vaccine producing Sudan virus-like particles protects from lethal infection
por: Malherbe, Delphine C., et al.
Publicado: (2022)

Evaluation of Two Commercially Available DNA Tests for Detection of Human Papillomavirus
por: Halstead, Diane C., et al.
Publicado: (1995)

Cannot write session to /tmp/vufind_sessions/sess_sh4u70fb9af1vc61hhs4qc9bqk